These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 7120030)

  • 1. Cross-clamping of the thoracic aorta. Influence of aortic shunts, laminectomy, papaverine, calcium channel blocker, allopurinol, and superoxide dismutase on spinal cord blood flow and paraplegia in baboons.
    Svensson LG; Von Ritter CM; Groeneveld HT; Rickards ES; Hunter SJ; Robinson MF; Hinder RA
    Ann Surg; 1986 Jul; 204(1):38-47. PubMed ID: 3729582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inability of flunarizine, lidoflazine or magnesium to counteract delayed hypoperfusion after forebrain ischaemia in the rat.
    Grøgaard B; Gerdin B; Arfors KE
    Acta Neurochir (Wien); 1988; 95(3-4):136-42. PubMed ID: 3228003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flunarizine and verapamil: effects on central nervous system and peripheral consequences of cytotoxic hypoxia in rats.
    Dubinsky B; Sierchio JN; Temple DE; Ritchie DM
    Life Sci; 1984 Mar; 34(13):1299-306. PubMed ID: 6708731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cardiac arrest model in rats for evaluating the antihypoxic action of flunarizine.
    Hermans C; De Reese R; Van Loon J; Loots W; Jageneau AH
    Eur J Pharmacol; 1982 Jun; 81(1):137-40. PubMed ID: 7117366
    [No Abstract]   [Full Text] [Related]  

  • 5. Brain protective properties of etomidate and flunarizine.
    Wauquier A
    J Cereb Blood Flow Metab; 1982; 2 Suppl 1():S53-6. PubMed ID: 7085800
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection with flunarizine against hypoxic-ischaemic damage of the rat cerebral cortex. A quantitative morphologic assessment.
    Van Reempts J; Borgers M; Van Dael L; Van Eyndhoven J; Van De Ven M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):76-88. PubMed ID: 6870389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticonvulsive properties of cinnarizine and flunarizine in rats and mice.
    Desmedt LK; Niemegeers CJ; Janssen PA
    Arzneimittelforschung; 1975 Sep; 25(9):1408-13. PubMed ID: 1242663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of flunarizine against cerebral hypoxia-anoxia in mice and rats.
    Karasawa A; Kumada Y; Yamada K; Shuto K; Nakamizo N
    J Pharmacobiodyn; 1982 Apr; 5(4):295-300. PubMed ID: 7120030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Agents to improve cerebrovascular circulation and cerebral metabolism--flunarizine].
    Kurihara J; Kato H
    Nihon Rinsho; 1985 Feb; 43(2):402-5. PubMed ID: 3889415
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium-channel blockers in the treatment of migraine.
    Gelmers HJ
    Am J Cardiol; 1985 Jan; 55(3):139B-143B. PubMed ID: 3881906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flunarizine in the treatment of vertigo.
    Wouters L; Amery W; Towse G
    J Laryngol Otol; 1983 Aug; 97(8):697-704. PubMed ID: 6350513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flunarizine, a calcium channel blocker: a new prophylactic drug in migraine.
    Amery WK
    Headache; 1983 Mar; 23(2):70-4. PubMed ID: 6343298
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.